CFGS
VIVO

Concourse Financial Group Securities’s Meridian Bioscience Inc VIVO Stock Holding History

Concourse Financial Group Securities’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-121
Closed -$3.92K – 2341
2022
Q2 		$4K Buy
121
+25
+26% +$676 ﹤0.01% 1937
2022
Q1 		$2K Hold
96
– – ﹤0.01% 2074
2021
Q4 		$2K Hold
96
– – ﹤0.01% 2249
2021
Q3 		$2K Hold
96
– – ﹤0.01% 2270
2021
Q2 		$2K Sell
96
-9
-9% -$191 ﹤0.01% 2247
2021
Q1 		$3K Buy
+105
New +$2.5K ﹤0.01% 2103

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Concourse Financial Group Securities's VIVO Position: Q3 2022 in Review

Concourse Financial Group Securities sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 121 shares — an estimated $3.92K sold.

Concourse Financial Group Securities first reported a position in VIVO in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Concourse Financial Group Securities reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 121 Meridian Bioscience Inc shares in Q3 2022, an estimated $3.92K.
  • Concourse Financial Group Securities first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 6 quarters.
  • Concourse Financial Group Securities's Meridian Bioscience Inc position peaked at $4K in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Concourse Financial Group Securities's 13F filing for Q3 2022, filed 15 Nov 2022.